Partillion Bioscience Expands Access to Functional Cell Analysis at the 49th Annual Course in Cytometry

Researchers gained hands-on experience running Nanovial-based assays across commercial cell sorting platforms

LOS ANGELES, Sept. 2, 2026 /PRNewswire/ -- Partillion Bioscience trained researchers to run Nanovial-based functional assays on two commercial cell sorting platforms during the 49th Annual Course in Cytometry, held August 16–20, 2026, in La Jolla, California.

The week-long course paired lectures on panel design, spectral cytometry, and high-dimensional data analysis with laboratory sessions featuring major flow cytometry instrument manufacturers. It drew 54 attendees from industry, academia, nonprofit institutions, and shared core facilities.

"Flow cytometry may be a well-established field, but its capabilities continue to evolve," said Yoav Altman, host site organizer. "It is important to include technologies like Nanovials because they show attendees how existing cytometry infrastructure can support emerging applications, including secretion screening and cell-cell interaction assays." Altman co-organized the course with Carina Torres and Cheryl Kim of Cytometry Educational Associates, Inc.

Lowering the Barrier to Functional Cell Analysis
Nanovials make cell function sortable by capturing secreted molecules and maintaining defined cell-cell interactions. Researchers can then screen and recover live cells based on behavior rather than physical and molecular markers alone.

During the course, attendees ran Nanovial workflows on an imaging-enabled cell sorter and a sorter operating in large-particle mode. These instruments are two examples within a broader range of leading commercial flow cytometry platforms compatible with Nanovials.

This compatibility allows laboratories and core facilities to add secretion screening, cell-cell interaction studies, and functional TCR discovery without purchasing a dedicated screening instrument. By reducing the capital investment required, this approach positions Partillion to expand Nanovial adoption across the installed base of compatible cytometry instruments.

Scaling Adoption Through Training
Partillion pairs hands-on workshops with protocols and technical documentation to create a repeatable path from instrument compatibility to routine Nanovial use. Its session at the 49th Annual Course in Cytometry built on earlier training held in conjunction with the Cell-Cell Symposium at UCLA.

"Every researcher we train can bring Nanovial workflows back to their own team," said Joe de Rutte, Co-Founder and CEO of Partillion Bioscience. "When we train core facility experts and other power users, that impact multiplies, extending our reach from a single team to labs across an entire institution."

Partillion plans additional Nanovial workshops throughout the coming year to bring this approach to more researchers and core facility teams.

About Partillion Bioscience
Partillion Bioscience is pioneering a functional cell analysis platform built on its award-winning Nanovial technology. The company enables pharmaceutical and biotech partners to accelerate therapeutic development by screening millions of live cells in parallel and capturing critical functional outputs such as secretion, signaling, and viability.

Partillion's technology has been featured in Nature Nanotechnology, Nature Communications, Nature Protocols, PNAS, Science Advances, and ACS Nano, and recognized with the 2020 SLAS Innovation Award, 2022 SLAS New Product Award, and 2025 CYTO Innovation & Technology Showcase Award.

Learn more at www.partillion.com or contact [email protected].

SOURCE Partillion Bioscience